NCT05278260CompletedEarly phase 1
Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients
Hydrogen Rich Water to Mitigate Acute Mucositis During Radiation Therapy
Source: ClinicalTrials.gov · Last updated 14 May 2025
Brief summary (registry, in English)
This study explores the effects of hydrogen-rich water on alleviating the radiation-induced acute mucositis in head and neck cancer patients
- Status (registry)
- Completed
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- First submitted
- 3 Mar 2022
- Start date
- 25 May 2022
- Primary completion date
- 13 Nov 2024
- Lead sponsor
- Stony Brook University
- Diseases
- Head and neck cancer
- NCT number
- NCT05278260
What you commit to
- Study type: Interventional · Early phase 1
- Participants enrolled: 24
- From 25 May 2022 to the primary completion date, 13 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Diagnosis of a biopsy proven head and neck cancer, early or advanced stage, primary or recurrent tumor,
- Planning to receive daily fractionated radiotherapy for over 4 weeks' duration
- Karnofsky Performance Score (KPS) of at least 70
- Able to describe pain
- Able to swallow food and water
- Able to sign consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stony Brook Cancer Center Coordinator of this site? Confirm its status | Stony Brook | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.